McGill University Health Centre ( Site 0604)

Montreal, Quebec H4A 3J1

1 studies enrolling now · 2 studies all time

What they study most

Cutaneous Squamous Cell Carcinoma, Endometrial Cancer, Solid Tumor

Studies at this site

• A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) — Recruiting now
• Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) — Completed